Terry L. Murdock
2018
In 2018, Terry L. Murdock earned a total compensation of $2.7M as Chief Operating Officer at G1 Therapeutics, a 139% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $152,460 |
|---|---|
| Option Awards | $2,207,165 |
| Salary | $351,000 |
| Other | $38,125 |
| Total | $2,748,750 |
Murdock received $2.2M in option awards, accounting for 80% of the total pay in 2018.
Murdock also received $152.5K in non-equity incentive plan, $351K in salary and $38.1K in other compensation.
Rankings
In 2018, Terry L. Murdock's compensation ranked 4,252nd out of 14,244 executives tracked by ExecPay. In other words, Murdock earned more than 70.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,252 out of 14,244 | 70th |
Division Manufacturing | 1,576 out of 5,762 | 73rd |
Major group Chemicals And Allied Products | 564 out of 2,125 | 74th |
Industry group Drugs | 471 out of 1,814 | 74th |
Industry Pharmaceutical Preparations | 364 out of 1,388 | 74th |
Source: SEC filing on April 30, 2019.
Murdock's colleagues
We found five more compensation records of executives who worked with Terry L. Murdock at G1 Therapeutics in 2018.